Zydus Wellness, which acquired Complan in 2019, is rewriting the playbook—expanding the brand beyond kids, tapping into digital commerce, and leveraging scientific credibility to solidify its ...

(Reuters) -India’s Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France’s Amplitude Surgical for 256.8 million euros (nearly $280 million) as part of its plans to expand further ...

Zydus Wellness Ltd share price was down by -1.56% from the previous closing price of ₹1,632.65. Who are peers of Zydus Wellness Ltd? The peers of Zydus Wellness Ltd are Hindustan Unilever Ltd ...

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company, with support from the Gates Foundation, will carry out ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

High Conviction Stocks Idea Attributes-Company: a) Sound / resilient business; b) Consistent strong financials; c) High growth potential; and d) High return on invested capital.Industry: a) Market ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company is ready to launch the season's first India's Flu protection as per WHO recommended composition of quadrivalent influenza virus ...

One of the effective methods for assessing whether a stock is undervalued or overvalued is by analysing key metrics such as the Price-to-Earnings (P/E) ratio and the industry P/E average. The P/E ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...